Background Post‐thrombotic syndrome (PTS) is a frequent chronic complication of deep
vein thrombosis (DVT). Objective In the BioSOX study, we investigated whether inflammation …

Background: The aim of this study was to investigate whether inflammatory markers
(interleukin-6 [IL-6] and C-reactive protein [CRP]) in the acute phase of deep vein …

Background The postthrombotic syndrome (PTS) is a chronic complication of deep vein
thrombosis (DVT). Inflammation may contribute to its pathophysiology. Objectives We …

The post-thrombotic syndrome (PTS) occurs frequently after deep venous thrombosis (DVT)
despite appropriate anticoagulant therapy. A close relationship between inflammation and …

Objective Inflammation may play a role in pathogenesis of venous thromboembolism, but the
nature of this relationship is not yet understood. The objective of this study was to assess …

The post-thrombotic syndrome (PTS), which refers to chronic clinical manifestations of
venous insufficiency after a deep vein thrombosis (DVT), is a frequent occurrence. Because …

Background: Post‐thrombotic syndrome (PTS) occurs in 20–50% of patients after a deep
venous thrombosis (DVT). It is difficult to accurately predict which patients will develop PTS …

Deep vein thrombosis is a common disease associated with a variety of complications
including post-thrombotic syndrome as a late complication. It is now clear that in addition to …

The post thrombotic syndrome (PTS) develops in 20–40% of deep venous thrombosis (DVT)
patients. Risk factors for PTS have not been well elucidated. Identification of risk factors …

Introduction Post-thrombotic syndrome (PTS) is a limiting long-term complication present in
20–50% of patients with deep venous thrombosis (DVT) of the lower limbs. A panel of …